There’s No Getting Around Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Success

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

MRVI belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Maravai LifeSciences Holdings Inc is $511.83M. A total of 1.28 million shares were traded on the day, compared to an average of 3.36M shares.

In the most recent transaction, ORESHACK KURT sold 25,000 shares of MRVI for 5.03 per share on Jan 31 ’25. After the transaction, the General Counsel now owns 167,618 company shares. In a previous transaction on Jan 31 ’25, ORESHACK KURT bought 25,000 shares at 5.03 per share.

Among the insiders who bought shares, DeFord John A acquired of 17,500 shares on Nov 12 ’24 at a per-share price of $5.75. This resulted in the Director holding 70,046 shares of MRVI after the transaction. In another insider transaction, HULL CARL bought 175,000 shares at $5.64 per share on Nov 11 ’24. Company shares held by the insider now total 175,000.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, MRVI has a high of $11.56 and a low of $1.66.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MRVI’s latest balance sheet shows that the firm has $551.27M in Cash & Short Term Investments as of fiscal 2021. There were $575.22M in debt and $93.78M in liabilities at the time. Its Book Value Per Share was $2.29, while its Total Shareholder’s Equity was $545.36M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRVI is Buy with a score of 3.73.

Most Popular

Related Posts